Personalized PseudoPatient™ Receives 510(k) FDA Clearance
RTsafe introduces the new generation of dosimetry phantoms: the PseudoPatient™
As radiation therapy becomes even more customizable to each individual patient, the complexities of the supporting treatment planning system (TPS) and the dose delivery system increase. This in turn, requires a constant evolution of quality assurance (QA) methods used to verify the performance of the systems and to implement reliable End-to-End QA and plan/treatment verification in clinical practice.


  • Reference PseudoPatient™ for SRS/SRT
    RTsafe has developed high-fidelity Reference PseudoPatient™ 3D printed head phantoms of standard dimensions which enable customers to perform quality assurance end-to-end testing of their SRS/SRT systems with a high level of precision and accuracy.
  • Reference PseudoPatient™ for SBRT
    RTsafe 3D printed Reference PseudoPatient™ phantoms for SBRT are uniquely constructed to enable high accuracy dosimetric analysis and quality assurance evaluation of challenging spine radiosurgery cases testing compliance to TG-51 guidelines.
  • Personalized PseudoPatient™ for SRS/SRT
    RTsafe produces PseudoPatient™ dosimetry phantoms, built from real patient anatomical data, by combining proven expertise in medical physics with highly accurate 3D printing technology.
  • RTcompare software
    RTcompare is a DICOM-RT Viewer and Dose Distribution Comparison tool for radiotherapy treatment plans evaluation.

Services from RTsafe

  • RTsafe’s polymer gel dosimeter, RTgel-100, is combined with PseudoPatient™ or any other dosimetry phantom for comprehensive 3D remote dosimetry services.
  • Multi-level comparison of film-measured and TPS calculated dose distributions by using film batches calibrated in a Secondary Standard Laboratory.
  • RTsafe offers advanced MRI QA services with emphasis to Radiotherapy
For any additional information required, please fill out the form and an RTsafe representative will respond to your request.


Hygeia Hospital Adopts RTsafe Technology to Enhance Patient-specific Safety in Brain Cancer Radiotherapy
27 Nov 2018
Join RTsafe at ASTRO 2018 in San Antonio
18 Sep 2018
RTsafe Receives 510(k) FDA Clearance for Personalized Radiotherapy Verification Product for Brain Cancer Treatment
18 Jul 2018